Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 4
2007 10
2008 8
2009 12
2010 15
2011 15
2012 11
2013 13
2014 17
2015 22
2016 20
2017 10
2018 14
2019 11
2020 17
2021 13
2022 12
2023 14
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: yang dh. Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996. Haematologica. 2023. PMID: 36200417 Free PMC article.
Exploring cellular immunotherapy platforms in multiple myeloma.
Vo MC, Jung SH, Nguyen VT, Tran VD, Ruzimurodov N, Kim SK, Nguyen XH, Kim M, Song GY, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ. Vo MC, et al. Among authors: yang dh. Heliyon. 2024 Mar 13;10(6):e27892. doi: 10.1016/j.heliyon.2024.e27892. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38524535 Free PMC article. Review.
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.
Baek DW, Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, Lee E, Lee JH, Lee JO, Park SK, Kim SJ, Yoo KH, Yoon SS, Koh Y, Kang HJ, Won JH, Lyu CJ, Hahn SM, Lee JH, Park JS, Jo JC, Mun YC, Yang DH, Song GY, Lim SN, Sohn SK; Korean Society of Blood and Marrow Transplantation. Baek DW, et al. Among authors: yang dh. Blood Cancer J. 2023 Jun 26;13(1):95. doi: 10.1038/s41408-023-00868-w. Blood Cancer J. 2023. PMID: 37365207 Free PMC article.
Adrenal insufficiency in hospitalized patients with multiple myeloma.
Ahn SY, Kim HK, Kang HC, Kim M, Song GY, Jung SH, Ahn JS, Yang DH, Kim HJ, Lee JJ. Ahn SY, et al. Among authors: yang dh. Leuk Lymphoma. 2021 Feb;62(2):501-503. doi: 10.1080/10428194.2020.1834095. Epub 2020 Nov 2. Leuk Lymphoma. 2021. PMID: 33135942 No abstract available.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Kim DY, Kim YR, Suh C, Yoon DH, Yang DH, Park Y, Eom HS, Lee JO, Kwak JY, Kang HJ, Hyun SY, Jo JC, Chang MH, Yoo KH, Lim SN, Shin HJ, Kim WS, Kim IH, Kim MK, Kim HJ, Lee WS, Mun YC, Kim JS. Kim DY, et al. Among authors: yang dh. Am J Gastroenterol. 2023 Aug 1;118(8):1373-1380. doi: 10.14309/ajg.0000000000002185. Epub 2023 Jan 13. Am J Gastroenterol. 2023. PMID: 36728217
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
Park C, Lee HS, Kang KW, Lee WS, Do YR, Kwak JY, Shin HJ, Kim SY, Yi JH, Lim SN, Lee JO, Yang DH, Jang H, Choi B, Lim J, Sun CH, Byun JM, Yoon SS, Koh Y. Park C, et al. Among authors: yang dh. Nat Commun. 2024 Mar 30;15(1):2776. doi: 10.1038/s41467-024-47198-4. Nat Commun. 2024. PMID: 38555311 Free PMC article. Clinical Trial.
209 results